HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.

Abstract
Circular RNAs play an imperative role in cancer development and metastasis by regulating oncogenic and tumor-suppressive pathways. However, the role and mechanism of circ_0074027 in non-small-cell lung cancer (NSCLC) have not been elucidated. The expression levels of circ_0074027 were detected by qRT-PCR. The link between circ_0074027 expression and clinicopathologic parameters was analyzed by Fisher's exact test. The prognostic role of circ_0074027 was investigated by Kaplan-Meier and Cox regression analysis. Cell counting kit-8 and flow cytometric assays were utilized to evaluate NSCLC cell proliferation and apoptosis, respectively. Wound scratch and Transwell tests were applied to detect cell migratory and invasive capacities. The interaction potential of circ_0074027 and miR-185-3p was analyzed by the circBank database, and verified by dual-luciferase reporter assay. The downstream gene of miR-185-3p was also investigated. Circ_0074027 was elevated in NSCLC specimens and cell lines. Overexpressed circ_0074027 was related to more advanced TNM stages, poorer differentiation grade, and worse overall survival. Upregulated circ_0074027 increased the proliferation of H1299 cells by inhibiting cell apoptosis. Cell migration and invasion were enhanced after circ_0074027 overexpression. Silenced circ_0074027 caused the opposite effects in the A549 cell line. For mechanism investigation, circ_0074027 directly sponges miR-185-3p to enhance bromodomain-containing protein 4 (BRD4) and MAPK-activating death domain-containing protein (MADD) expression levels at the posttranscriptional level. Furthermore, we found the oncogenic function of circ_0074027 is attributed to its modulation of BRD4 and MADD. Collectively, upregulated circ_0074027 in NSCLC accelerates cell progression via miR-185-3p/BRD4/MADD pathway as a competing endogenous RNA.
AuthorsPing Gao, Zhidong Wang, Zhanliang Hu, Xuan Jiao, Yue Yao
JournalJournal of cellular biochemistry (J Cell Biochem) Vol. 121 Issue 3 Pg. 2632-2642 (03 2020) ISSN: 1097-4644 [Electronic] United States
PMID31680319 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2019 Wiley Periodicals, Inc.
Chemical References
  • BRD4 protein, human
  • Biomarkers, Tumor
  • Cell Cycle Proteins
  • Death Domain Receptor Signaling Adaptor Proteins
  • Guanine Nucleotide Exchange Factors
  • MADD protein, human
  • MIRN185 microRNA, human
  • MicroRNAs
  • RNA, Circular
  • Transcription Factors
Topics
  • Apoptosis
  • Biomarkers, Tumor (genetics, metabolism)
  • Carcinoma, Non-Small-Cell Lung (genetics, metabolism, pathology)
  • Cell Cycle Proteins (genetics, metabolism)
  • Cell Movement
  • Cell Proliferation
  • Death Domain Receptor Signaling Adaptor Proteins (genetics, metabolism)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Guanine Nucleotide Exchange Factors (genetics, metabolism)
  • Humans
  • Lung Neoplasms (genetics, metabolism, pathology)
  • Male
  • MicroRNAs (genetics)
  • Middle Aged
  • Neoplasm Invasiveness
  • Prognosis
  • RNA, Circular (genetics)
  • Survival Rate
  • Transcription Factors (genetics, metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: